1.Clinical Use of Cephalosporins.
Kyung Hee CHANG ; June Myung KIM
Journal of the Korean Medical Association 2000;43(7):670-677
No abstract available.
Cephalosporins*
2.Effects of salicylates on the susceptibility of klebseilla pneumoniae to cephalosporins.
Phil Youl RYU ; Seung Ryong GOO ; Sun Sick CHUNG
Journal of the Korean Society for Microbiology 1993;28(2):95-103
No abstract available.
Cephalosporins*
;
Pneumonia*
;
Salicylates*
3.Cefepime Neurotoxicity in Patients with Renal Insufficiency.
Seon Yu KIM ; In Sik LEE ; Seung Lee PARK ; Jongmin LEE
Annals of Rehabilitation Medicine 2012;36(1):159-162
Cefepime is a fourth-generation cephalosporin that is active against both gram-positive and gram-negative organisms. It is administered parenterally for the treatment of severe infections. Approximately 85% of the drug is excreted unchanged by the kidneys. Neurotoxicity in patients with renal failure who are treated with cefepime has been reported sporadically. We report on two senile patients with renal impairment who developed neurotoxicity including lethal outcome after treatment with cefepime.
Cephalosporins
;
Humans
;
Kidney
;
Renal Insufficiency
4.A retrospective cohort study comparing the cure rates of ampicillin, chloramphenicol, ampicillin and chloramphenicol combination, and third generation cephalosporins as initial antibiotic therapy for invasive Haemophilus influenzae infections
Pediatric Infectious Disease Society of the Philippines Journal 2013;14(1):34-41
Background/Objective:
Haemophilus influenzae type b remains to be a significant etiology of invasive infections specially in children two months to five years old without Hib vaccination. This study was performed to compare the cure rates of ampicillin, chloramphenicol, ampicillin-chloramphenicol combination and third generation cephalosporins as initial antibiotic treatments for documented invasive Hib infections. This study may assist in formulating recommendations on empiric antimicrobial therapy.
Methods:
Charts of patients with invasive Hib disease confirmed either by blood culture, CSF culture and/or latex agglutination test from January 1991 to August 2010 were reviewed. Cases were classified into four groups depending on the initial antibiotic given upon admission. The four groups were compared and analyzed in terms of cure rates.
Results
The disease occurred predominantly in children less than two years old. Males were more frequently affected than females. All subjects were not given Hib vaccination. Cure rates were significantly different between ampicillin (33%) and chloramphenicol (89%) groups (p=0.017), and between chloramphenicol (89%) and ampicillin-chloramphenicol (39%) groups (p=0.008). However, cure rates were not significantly different when third generation cephalosporin group (62%) was compared to the other treatment groups (p>0.05). Resistance of Hib was 31% to ampicillin, while <10% to chloramphenicol and third generation cephalosporins. Conclusion: Chloramphenicol is an excellent drug for empiric therapy in highly suspected or proven cases of invasive Hib disease.
Ampicillin
;
Chloramphenicol
;
Third Generation Cephalosporins
;
Haemophilus influenzae
5.Fermentation process monitoring and fault detection based on dynamic MPCA.
Chinese Journal of Biotechnology 2006;22(3):483-487
A dynamic multiway principle component analysis for on-line batch process monitoring and fault detection was proposed. It integrates the time-lagged windows of process dynamic behavior with the multiway principle component analysis (MPCA). Using multi-model instead of single model, the dynamic MPCA approach emphasizes particularly on-line process performance monitoring and fault defecting. On-line process monitoring of cephalosporin C fermentation was studied, the results demonstrate that the dynamic MPCA method is able to efficiently monitor performance of the fermentation process and exactly detect faults which results in extraordinary behavior of processes.
Cephalosporins
;
biosynthesis
;
Fermentation
;
Forecasting
;
Nonlinear Dynamics
;
Principal Component Analysis
;
methods
6.Evaluation of Automated Blood Bank Systems AutoVue Innova and QWALYS-3 for ABO-RhD Grouping and Antibody Screening.
Tae Kyu AN ; Yoon Kyung SONG ; Hee Seoung SEO ; Kang Lim KIM ; Jung Ah KIM ; Chang Ha KO ; Do Hoon LEE ; Sun Young KONG
Korean Journal of Blood Transfusion 2012;23(3):204-209
BACKGROUND: Introduction of automation instruments for the blood bank is essential in order to reduce inspection error and minimize workload. We compared the results of ABO-RhD blood type and antibody screening tests using the manual method and those using the automation instruments AutoVue Innova (Ortho-Clinical Diagnostics, Raritan, NJ, USA) and QWALYS-3 (DIAGAST, Loos Cedex, France). METHODS: ABO-RhD blood type tests using the slide method, the tube method, and the instruments were performed with 200 selected samples. Antibody screening tests using the Ortho BioVue system (Ortho-Clinical Diagnostics, Raritan, NJ, USA), which is used in our laboratory, and the two instruments were performed with 188 specimens and 12 antibody positive samples that were kept in the laboratory. We evaluated the concordance rate of the results, applying CLSI guideline EP12-A2. RESULTS: The concordance rate of ABO-RhD blood type results between the manual methods and the two instruments was 100%. On antibody screening tests, a concordance rate of 100% was observed between the manual method and AutoVue Innova, which uses the gel card manufactured by the company making the gel card used for the manual method. However, using QWALYS-3 in performance of antibody screening tests, the concordance rate was 97.5%, because of discordance in five specimens. CONCLUSION: The concordance rate of ABO-RhD blood type by use of two automation instruments was 100%, however, that of the antibody screening test was 97.5%. Thus, there was a difference in positive rate on the antibody screening test, depending on the instrument. Therefore, introduction of an instrument, considering the pros and cons for each instrument, is necessary. In addition, further discussion of standardized guidelines for quality control is needed.
Automation
;
Blood Banks
;
Cephalosporins
;
Mass Screening
;
Quality Control
7.Cefepime-Induced Reversible Encephalopathy with Triphasic Waves in Patients with Impaired Renal Function.
Jeong Am RYU ; Sun Min LEE ; Jae Il KIM ; Geun Ho LEE ; Chang Min LEE ; Young Mok SONG ; Jee Hyun KIM
Journal of Korean Epilepsy Society 2009;13(1):15-18
Cefepime is a widely used beta-lactam antibiotic. We first report two cases of cefepime-induced reversible encephalpathy in Korea. Two patients with renal impairment presented stupor while being treated with cefepime for pneumonia, one of whom also developed myoclonus and asterixis. Their electroencephalogram showed triphasic waves despite of normal liver function. After discontinuation of cefepime, they completely recovered with normalization of electroencephalogram. Early recognition of cefepime-induced encephalopathy and immediate withdrawal of cefepime would be important for the prognosis of the patients.
Cephalosporins
;
Dyskinesias
;
Electroencephalography
;
Humans
;
Korea
;
Liver
;
Myoclonus
;
Pneumonia
;
Prognosis
;
Stupor
8.Clostridium tertium Bacteremia in a Non-neutropenic Patient with Small Bowel Obstruction.
Nam Su KU ; Hae Sun CHUNG ; Jae Gil LEE ; Sun Bean KIM ; Sang Hoon HAN ; Jun Yong CHOI ; Kyungwon LEE ; June Myung KIM
Infection and Chemotherapy 2011;43(4):355-358
Clostridium tertium-induced bacteremia is a rare condition seen predominantly in neutropenic patients and/or patients with gastrointestinal disease. In this report, we describe a non-neutropenic, 72-year-old patient with a small bowel obstruction who presented with C. tertium bacteremia. Clostridium tertium is aerotolerant and resistant to broad-spectrum cephalosporins. The aerotolerant nature of C. tertium is resulted in delayed identification and reporting since it is not initially considered a candidate for infection.
Aged
;
Bacteremia
;
Cephalosporins
;
Clostridium
;
Clostridium tertium
;
Gastrointestinal Diseases
;
Humans
9.The Trend of Antibiotics Usage in Korea during 1981-1998.
Sang Il KIM ; Jae Myung PARK ; Seong Heon WIE ; Yang Ree KIM ; Moon Won KANG
Korean Journal of Infectious Diseases 2000;32(6):439-447
BACKGROUND: With the time course, the cost and the amounts of produced antibiotics are increasing but it is difficult to get the exact data and there were limitations to know the trend of antibiotics usage. So we examined the trend of antibiotics usage every five year during 1981-1998 by using two parameters; the cost and the amount of antibiotics produced in South Korea. METHODS: We used the data from 'Annual products of medicine' published by Korea Pharmaceutical Manufactures Association. Every antibiotics were classified to generic names, and the cost and the amounts of produced antibiotics were compared each year. RESULTS: In 1998, the total cost of produced antibiotics was 1,150 billion won and the amount was 708.6 ton. The cost was increased by 20.0% compared to that of 1995. Cephalosporins made the largest proportion of the cost in antibiotic production that was 43.8% (503.3 billion won) in 1998. With the time course proportion of the third and the second generation cephalosporins were increased. Penicillins made the largest proportion (46%) of the total amount and were produced 325.7 ton. Among them, aminopenicillins were 86% of the total cost of penicillins and 95% of the total amount of penicillins. Especially the cost of aminopenicillins with beta-lactamase inhibitor was 2.3 times increased since 1993 thus made the major cause of increase. Quinolones were increased 2.1 times and macrolides were increased 2.2 times in production cost for 5 years. Tetracyclines, lincosamides and chloramphenicols were decreased in both production cost and amount, but penicillins and macrolides were increased in production cost even though production amounts were decreased. CONCLUSION: There seemed to be an increase in the cost and the amount of antibiotic production in Korea. Especially productions of newer drugs such as aminopenicillins with beta-lactamase inhibitor, third generation cephalosporins, some of macrolides and carbapenems were increased remarkably. And the use of glycopetides, anti-fungal agents, and antiviral agents were increasing also. Some drugs were thought to be an inappropriate use. More epidemiologic study and the guidelines for the proper use of antibiotics are needed.
Anti-Bacterial Agents*
;
Antiviral Agents
;
beta-Lactamases
;
Carbapenems
;
Cephalosporins
;
Chloramphenicol
;
Korea*
;
Lincosamides
;
Macrolides
;
Penicillins
;
Quinolones
;
Tetracyclines
10.Beta-Lactam Allergy and Cross-Reactivity.
Korean Journal of Medicine 2014;87(6):652-658
Penicillins and cephalosporins are commonly prescribed beta-lactam antibiotics that are able to induce severe and sometimes even life-threatening hypersensitivity reactions. These reactions can be broadly classified as immediate or non-immediate/delayed depending on the onset of the reaction after the last drug administration. A definitive diagnosis of beta-lactam hypersensitivity is required to carry out the proper preventive measures. The diagnostic approach to beta-lactam allergy should be considered if the risk/possible benefit ratio is positive. In Korea, however, the diagnostic approach to beta-lactam allergy remains a major challenge. Major and minor determinants of penicillin for skin testing are unavailable, making skin testing appear to be less sensitive. Drug allergy work-ups that include standardized skin tests, reliable in vitro tests, and drug provocation tests are rarely carried out in clinical practice. However, screening patients without a prior history of beta-lactam allergy is routinely recommended. In this review, we discuss practical evaluation of beta-lactam allergy and cross-reactivity between penicillins and cephalosporins.
Anti-Bacterial Agents
;
Cephalosporins
;
Diagnosis
;
Drug Hypersensitivity
;
Humans
;
Hypersensitivity*
;
Korea
;
Mass Screening
;
Penicillins
;
Skin Tests